This Healthcare Stock Might Just Be RFK Jr. Proof
Thermo Fisher Scientific should be safe. RFK Jr. may disrupt Big Pharma, but he’s unlikely to cause research to completely grind to a halt.
Thermo Fisher’s Promising Outlook and Strategic Management Drive Analyst’s Positive Rating
In a report released today, Daniel Brennan from TD Cowen maintained a Buy rating on Thermo Fisher (TMO – Research Report), with a price target ...
Analyst Expectations For Thermo Fisher Scientific's Future
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $654.0, with a high estimate of $680.00 and a low estimate of $605.00. Experiencing a 1.36% ...
Hosted on MSN1mon
Is Thermo Fisher Scientific (NYSE:TMO) the Best Low Volatility Stock to Buy Right Now?
In this article, we are going to take a look at where Thermo Fisher Scientific Inc ... In a CNBC interview, Alan Rechtschaffen, Senior Portfolio Manager at UBS Global Wealth, stressed that ...